Pfizer recalls Indian-made intravenous drugs

June 7, 2010
Manufacturing and Production Claris Lifesciences, Pfizer, manufacturing compliance, recalls

Pfizer is recalling two intravenous antibiotics and an anti-nausea medication after particulate matter was found to be floating in them, leading …

Teva will invest $56m in Canadian plant

June 7, 2010
Manufacturing and Production Canada, Teva, production

Israeli generic drugmaker Teva Pharmaceutical Industries is planning to spend $54 million to expand a Canadian production plant for solid …

Careers Voice: Online recruitment? Don’t take it at face value

June 7, 2010
Business Services careers voice, rsa

With social networking and online sites offering low cost solutions, are the days of traditional recruitment firms numbered? Without face-to-face …

UCB’s Kola joins Astex board

June 5, 2010
Research and Development Astex, UCB, appointment, research and development

Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …

Sanofi signs deal on pre-clinical cancer drugs

June 4, 2010
Research and Development Cancer, Sanofi

Sanofi-Aventis has signed a deal with US biotech company Ascenta to co-develop new oncology treatments aimed at restoring ‘apoptosis’ or …

ASCObag

ASCO cancer conference opens

June 4, 2010
Research and Development ASCO, Cancer, lenalidomide, rituximab

One of the most important dates in the pharmaceutical industry’s calendar, the ASCO cancer conference begins today. The American Society …

Vaccine for brain cancer shows promise

June 3, 2010
Research and Development Cancer, GBM, ImmunoCellular

Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …

NICE rejects Xolair for children

June 3, 2010
Sales and Marketing NICE, Xolair, asthma

The drug was first approved in Europe in November 2005 for patients aged 12 or older, and gained NICE approval …

Ogilvy wins Pradaxa account

June 3, 2010
Medical Communications Boehringer, Ogilvy, Pradaxa

Boehringer Ingelheim has awarded OgilvyHealthPR the global communications brief for its oral blood-thinner Pradaxa. The agency was appointed after a …

Erbitux ‘now standard of care’ in KRAS patients

June 3, 2010
Sales and Marketing Erbitux, Merck Serono

A new survey suggests Merck Serono’s Erbitux has become a standard of care for KRAS wild-type metastatic colorectal cancer The …

Teva staff in Ireland vote for industrial action

June 3, 2010
Manufacturing and Production Ireland, Teva

Workers at a plant operated by Teva in Ireland have voted to take industrial action in a dispute over redundancy …

iPhone

Pfizer launches iPhone service for doctors

June 3, 2010
Medical Communications Apple, Epocrates, Pfizer, digital doctors, emedicine, iphone

A new service to allow doctors to communicate with Pfizer via iPhones and other mobile devices has been unveiled. Clinicians …

Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre

June 3, 2010
Research and Development

Chiltern will draw upon many parts of TAHSC, including the Clinical Research Centre (CRC) which is located on the same …

Leo chooses Cegedim for Asia Pacific

June 2, 2010
Business Services Asia, CRM

Leo Pharma has chosen a Cegedim Dendrite CRM system for its sales teams in Asia Pacific. ‘Mobile Intelligence’ is a …

NICEweb

Thalidomide recommended ahead of Velcade

June 2, 2010
Medical Communications NICE, myeloma

Celgene’s Thalidomide has been recommended by NICE as a treatment for multiple myeloma, and is favoured ahead of Janssen-Cilag’s Velcade. …

Xeloda for gastric cancer gains NICE nod

June 2, 2010
Sales and Marketing UK, Xeloda

NICE has recommended Roche’s Xeloda as a first line treatment of inoperable advanced gastric cancer.The cost-effectiveness body says the oral …

Tim Mustill joins Acumed

June 2, 2010
Medical Communications Acumed, KnowledgePoint360, appointment, medical communications

Tim Mustill has been appointed vice-president of client services at Acumed, part of the KnowledgePoint360 medical communications group. He has …

Amgen’s Prolia approved in Europe

June 1, 2010
Sales and Marketing Amgen, Prolia

A blockbuster future is predicted for the osteoporosis treatment Prolia, with global sales predicted to reach $5 billion.European regulators have …

Global MS awareness campaign launched

June 1, 2010
Medical Communications MS, Merck Serono

Merck Serono has launched a short film competition as part of a global campaign, Real MS, to raise awareness of …

‘Phantom recall’ dogs J&J at congressional hearing

June 1, 2010
Manufacturing and Production Johnson & Johnson, McNeil, Tylenol, manufacturing compliance

Johnson & Johnson subsidiary McNeil Consumer Healthcare initiated a recall of its painkiller Motrin (ibuprofen) last year without informing the …

The Gateway to Local Adoption Series

Latest content